Soleno Therapeutics (SLNO) EPS (Basic) (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly EPS (Basic) of $0.6 for Q1 2026, up 163.55% year-over-year from $0.23 in Q1 2025, and down 29.4% quarter-over-quarter from $0.85 in Q4 2025.
Soleno Therapeutics (SLNO) EPS (Basic) (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported EPS (Basic) for 13 consecutive years, with $0.6 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 163.55% year-over-year to $0.6; the TTM figure through Mar 2026 stood at -$3.56 (up 55.02% YoY), while the FY2025 annual figure was -$1.05, up 83.67% from the prior year.
- EPS (Basic) declined to $0.6 in Q1 2026 per SLNO's latest filing, from $0.85 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.85 in Q4 2025 and bottomed at -$7.46 in Q4 2022.
- Historically, EPS (Basic) has averaged -$1.95 across 5 years, with a median of -$1.17 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 1221.72% — and 2026, when it surged 163.55%.
- Soleno Therapeutics' EPS (Basic) stood at -$7.46 in 2022, then jumped by 90.37% to -$0.72 in 2023, then slumped by 93.18% to -$1.39 in 2024, then soared by 161.5% to $0.85 in 2025, then fell by 29.4% to $0.6 in 2026.
- Business Quant data shows SLNO's EPS (Basic) at $0.6 in Q1 2026, $0.85 in Q4 2025, and -$1.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.85 |
| Sep 30, 2025 | -1.62 |
| Jun 30, 2025 | -3.45 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -1.39 |
| Sep 30, 2024 | -4.15 |
| Jun 30, 2024 | -2.38 |
| Mar 31, 2024 | -2.76 |
| Dec 31, 2023 | -0.72 |
| Sep 30, 2023 | -5.09 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -0.90 |
| Dec 31, 2022 | -7.46 |
| Sep 30, 2022 | -0.80 |
| Jun 30, 2022 | -0.89 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | -0.56 |
| Sep 30, 2021 | -1.57 |
| Jun 30, 2021 | -2.20 |